Johnson & Johnson to buy Micrus Endovascular
Johnson & Johnson agrees to pay $23.40 per share in cash for Micrus Endovascular Corp., which makes devices to treat stroke and aneurysm in the brain. Johnson & Johnson (NYSE: JNJ) agreed to pay $480 million in cash to acquire Micrus Endovascular Corp. (NSDQ:MEND), a San Jose, Calif.-based maker of cerebral vascular devices. Micrus specializes […]